| A2A Pharma | Phase 1 | — | Oncology, Autoimmune Diseases |
| GlycoMira | Phase 1 | — | Oncology, Supportive Care |
| GenZum Life Sciences | Pre-clinical | — | Oncology, Immunology |
| Prescient Imaging | Commercial | — | Oncology |
| BioTillion | — | — | — |
| Lanier Biotherapeutics | Pre-clinical | — | Ophthalmology, Immunology |
| Nexien BioPharma | Pre-clinical | — | Neuroscience, Rare Disease |
| AdjuTec Pharma | Phase 1 | — | Infectious Disease, Antimicrobial Resistance |
| Recombinant Technologies | Pre-clinical | — | Alzheimer's Disease, Neurodegenerative Diseases |
| Atrogi | Phase 2 | — | Metabolic Disorders, Diabetes |
| Vandria | Phase 1 | — | CNS, Musculoskeletal |
| Alzeca Biosciences | Pre-clinical | — | Alzheimer's Disease, Neurodegenerative Diseases |
| EraCal Therapeutics | Pre-clinical | — | Obesity, Metabolic Disorders |
| STALICLA | Phase 2 | — | Neurodevelopmental Disorders, Autism Spectrum Disorder |
| Cellis | Pre-clinical | — | Oncology |
| Medherant | Phase 1 | — | Women's Health, Pain |
| OncoAssure | Commercial | — | Oncology |
| Sonivate Medical | Commercial | — | Point-of-Care Diagnostics, Procedural Guidance |
| Spire Therapeutics | Phase 3 | — | Chronic Pain, Depression |
| Bryn Pharma | Phase 3 | — | Allergy & Immunology |
| Trince | — | — | — |
| Solgate | Pre-clinical | — | — |
| MipSalus | Pre-clinical | — | Metabolic Disorders, Rare Diseases |
| MedRegen | Phase 2 | — | Acute Respiratory Distress Syndrome (ARDS), Wound Healing |
| Zhongmou Therapeutics | phase-2 | — | Oncology |